teplizumab-mzwv injection is a prescription medicine used to delay the onset of Stage 3 type 1 diabetes

Lixisenatide is a once-daily injectable GLP-1 receptor agonist for the treatment of type 2 diabetes.

Ertugliflozin is indicated for the treatment of adults with insufficiently controlled type 2 diabetes as an adjunct to diet and exercise as monotherapy.

Alogliptin is an oral anti-diabetic drug in the DPP-4 inhibitor (gliptin) class.

alogliptin and metformin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Exenatide, is a medication used to treat diabetes mellitus type 2.

Empagliflozin, is an antidiabetic medication used to improve glucose control in people with type 2 diabetes, to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease, to reduce the risk of death and hospitalization in people with heart failure and low or preserved ejection fraction, and to reduce the risk of cardiovascular death and hospitalization for heart failure in adults.

Empagliflozin/linagliptin, is a fixed-dose combination anti-diabetic medication used to treat type 2 diabetes.

Facilitating Access to Approved MedicationSemaglutide Injection Active Ingredient(s): SemaglutideTrade Name: On RequestPackaging: TInjectionStrength: Injection: 2 mg/1.5 mL (1.34 mg/mL) available in:  Single-patient-use pen that delivers 0.25 mg...

Facilitating Access to Approved MedicationTirzepatide Injection Active Ingredient(s): TirzepatideTrade Name: On RequestPackaging: InjectionStrength: 5 milligrams, 10 milligrams and 15 milligramsIndications: Tirzepatide injection to improve blood...